Roslin Foundation investment portfolio

Censo Biotechnologies Ltd supplies human stem‑cell products, including induced pluripotent stem cells, and provides contract research services for drug discovery, screening, toxicity testing and cell‑banking to pharmaceutical and biotechnology companies.

Roslin Cell Therapies Limited is a contract development and manufacturing organisation that provides cell‑therapy process development, manufacturing, storage, distribution and import‑export services for companies developing cell‑based medicinal products, including collaborations such as the CRISPR‑edited therapy exa‑cel for sickle‑cell disease and beta‑thalassaemia. Its services target biopharmaceutical developers seeking specialised CDMO capabilities for human cell‑therapy products.